The antitumor responses of the NF-κB trigger signaling cascade result in T-cell recruitment at the tumor site, leading to tumor regression and activation of chemokines and cytokines possessing the C–C motif and CCL2, respectively (Xia et al., 2014). The gene discussed is CCL2; the disease is neoplasm.